- Open Access
Recommendations for breastfeeding during Coronavirus Disease 2019 (COVID-19) pandemic
International Breastfeeding Journal volume 17, Article number: 28 (2022)
Coronavirus Disease 2019 (COVID-19) has spread worldwide. The safety of breastfeeding of SARS-CoV-2-positive women has not yet reached a consensus among the scientific community, healthcare providers, experts in lactation care, health organizations and governments. This study was conducted to summarize the latest evidence about the safety of breastfeeding among suspected/confirmed infected mothers and to summarize the recommendations on breastfeeding during COVID-19 from different organizations.
A comprehensive literature review of publications about the safety of breastfeeding among SARS-CoV-2-infected mothers was conducted. Scientific databases were searched up to 26 May 2021. The evidence was summarized into five perspectives according to a framework proposed by van de Perre et al. with certain modifications. Moreover, websites of different health organizations were visited to gather the recommendations for breastfeeding.
The current evidence demonstrated that the majority of infants breastfed by infected mothers were negative for SARS-CoV-2. Breast milk samples from suspected/infected mothers mainly demonstrated negative results in SARS-CoV-2 viral tests. There was insufficient evidence proving the infectivity of breast milk from infected mothers. Recent studies found other transmission modalities (e.g., milk containers, skin) associated with breastfeeding. Specific antibodies in the breast milk of infected mothers were also found, implying protective effects for their breastfed children. According to van de Perre’s criteria, the breast milk of infected mothers was unlikely to transmit SARS-CoV-2. Owing to the low quality of the current evidence, studies with a more robust design are needed to strengthen the conclusion regarding the safety of breastfeeding. Further studies to follow up the health status of infants who were directly breastfed by their suspected/infected mothers, to collect breast milk samples at multiple time points for viral tests and to examine specific antibodies in breast milk samples are warranted. Current recommendations on breastfeeding during COVID-19 from different organizations are controversial, while direct breastfeeding with contact precautions is generally suggested as the first choice for infected mothers.
This review determined the safety of breastfeeding and identified the focus for further research during the COVID-19 pandemic. Recommendations on breastfeeding are suggested to be updated in a timely manner according to the latest evidence.
Coronavirus Disease 2019 (COVID-19) is a viral infection caused by a novel coronavirus named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) . COVID-19 was characterized as a global pandemic by the World Health Organization (WHO) in March 2020 . To date, COVID-19 is still epidemic in most areas of the world, such as Europe, the Americas, and Southeast Asia . The pandemic is more serious in the Americas (contributing to 38.2% of cases and 46.1% of deaths) than in other areas. The North American region accounted for the highest proportions of cases (76%) and deaths (72%). The number of confirmed infected cases was 243,327,429 globally as of 23 October 2021, including 4,943,742 (2.03%) deaths .
Pregnant women and young children are susceptible to COVID-19 [5, 6]. During pregnancy, some adaptive immune responses in pregnant women are downregulated (e.g., the decrease in the number of T cells and B cells) . Additionally, the upper respiratory tract tends to be swollen due to high levels of estrogen and progesterone, and restricted lung expansion makes pregnant women susceptible to respiratory pathogens . As newborns do not have antibodies against coronaviruses, they are theoretically more vulnerable to SARS-CoV-2 infection . Therefore, lactation among infected mothers deserves special attention during this pandemic. Although the benefits of breastfeeding for mothers and children have been well acknowledged , SARS-CoV-2-positive women are still concerned about the risks of virus transmission from mother to infant during breastfeeding . There were two reviews on breastfeeding and COVID-19 published in 2020. Both recommended breastfeeding among infected mothers [10, 11]. However, much new evidence emerged in the following year. A comprehensive summary of the current evidence verifying the safety of breastfeeding among SARS-CoV-2-positive women is still needed. Moreover, recommendations put forwards by different national authorities and health organizations have been updated [8, 10, 12,13,14,15,16]. Evidence on the safety of breast milk from SARS-CoV-2-infected mothers and recommendations of breastfeeding practices that have not yet reached a consensus may lead to anxiety and affect the health and survival of young children.
To determine the plausibility of viral transmission by breast milk, van de Perre et al.  established an analytical framework using the underlying principles of Koch’s postulate. The framework was proposed to help clarify the relationship between breastfeeding exposure and viral infections and was based on five criteria: viral infection in children breastfed by infected mothers; the presence of virus/antigen/genome in the breast milk of infected mothers; the infectivity of virus in breast milk; attempts to rule out other transmission modalities; and the reproduction of transmission by breast milk in an animal model. If five criteria were met, there was 100% possibility of virus transmission. If four criteria were met, virus transmission was very likely to occur. If three criteria were met, virus transmission was possible. If two criteria and even fewer were met, virus transmission was unlikely .
The present review was conducted to summarize 1) the latest evidence about the safety of breastfeeding among SARS-CoV-2-infected mothers and 2) the recommendations on breastfeeding from different organizations during the COVID-19 pandemic. The analytical framework by van de Perre et al.  was adopted in the present review to summarize the existing evidence. In the current literature, animal studies about breastfeeding and SARS-CoV-2 transmission were not available. However, there have been studies reporting SARS-CoV-2-specific antibodies in the breast milk of infected mothers. As a result, modification of van de Perre’s framework  was made in the present review. This review might be useful to ensure optimal infant feeding practices, as well as maternal and child health over the critical period of the COVID-19 pandemic.
Search strategy and selection criteria
A comprehensive literature review of the publications on breastfeeding during COVID-19 to date was conducted. The scope of the literature search included databases of journal articles and official websites of the health organizations. Due to the authors’ language literacy, articles and recommendations written in English and Chinese were included.
Databases including PubMed, Scopus, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), and WANFANG DATA were searched up to 26 May 2021 regarding the evidence about the safety of breastfeeding among SARS-CoV-2-infected mothers. The key words for searching included “COVID-19”, “SARS-CoV-2”, “breastfeeding”, “formula feeding”, “breast milk”, “human milk”, “antibodies”, “antiviral”, “pregnant”, “infant”, “neonate”, and “newborn”. The reference lists of retrieved reviews were also manually searched. Journal articles, including those published online ahead of print, were included. The inclusion criteria were as follows: (1) the subjects were lactating mothers diagnosed with COVID-19 or SARS-CoV-2 infection; and (2) the study outcome was the safety of breast milk and/or the wellbeing of infants. The exclusion criteria were (1) conference abstracts, preprints, comments, and letters; (2) studies not published in Chinese or English; (3) studies for which the full text was not retrievable; (4) irrelevant studies; and (5) incomplete studies or studies without outcome information. Two researchers (XL and HC) independently searched, screened, and reviewed the literature. Disagreements were resolved by consulting a third researcher (MA). The evidence included in the present review was then summarized into five perspectives according to van de Perre’s framework  with certain modifications.
For recommendations, official websites of medical institutions and governmental and nongovernmental organizations were searched, including the American Academy of Pediatrics (AAP), Academy of Breastfeeding Medicine (ABM), U.S. Centers for Disease Control and Prevention (CDC), Italian National Institute of Health (ISS), International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), National Health Commission of the People’s Republic of China, Royal College of Obstetricians and Gynecologists (RCOG), United Nations International Children’s Emergency Fund (UNICEF), and WHO. The recommendations were then summarized into a table.
Evidence about the safety of breastfeeding
A total of 2677 articles were identified by the comprehensive literature search. After excluding duplicates, the titles, abstracts and full texts were screened. A total of 53 articles were included in this review (Fig. 1. Flowchart of the study selection). Of the included studies, 16 reported the infection status of infants who had been breastfed by infected mothers; 33 reported the results of SARS-CoV-2 detection in breast milk from infected mothers; five were associated with the infectivity of breast milk from infected mothers; four assessed other relevant transmission modalities associated with breastfeeding; and nine were associated with the protective effect of breast milk. The included studies were summarized into the following five perspectives according to the framework mentioned above .
Infection status of infants breastfed by infected mothers
Breastfed infants of SARS-CoV-2-positive mothers were followed-up with health assessments (Table 1). Among 16 studies included in this perspective, six found that breastfed children were positive for SARS-CoV-2. Notably, some breastfed infants who were positive for SARS-CoV-2 did not show clinical symptoms and turned negative several days later. In Italy , a preterm newborn was inadvertently fed with SARS-CoV-2-positive expressed breast milk. However, this newborn was not infected. Another study in Italy  showed that two breastfed infants tested SARS-CoV-2 positive 3 days and 7 days postpartum, respectively. However, both infants turned negative on the 14th day after delivery.
The likelihood of SARS-CoV-2 contained in breast milk
Thirty-three studies included in this review examined whether SARS-CoV-2 existed in breast milk samples collected from mothers with COVID-19 during pregnancy or lactation (Table 2). The RT-PCR method was conducted in all included studies to detect SARS-CoV-2 nucleic acid in breast milk samples.
There were 14 studies examining breast milk at a single time point and 14 studies examining breast milk at multiple time points. The majority of evidence demonstrated SARS-CoV-2 negative results in breast milk. For example, a study in Spain examined hand-expressed colostrum samples from seven infected women within the first hour of delivery; all seven breast milk samples tested SARS-CoV-2 negative . Similarly, in China, two separate studies (n = 6  and n = 10 ) reported that breast milk samples collected from infected mothers during their first lactation were found to be negative for SARS-CoV-2. Another two studies in China also reported negative results of breast milk samples collected from infected mothers at 36 h  and the sixth day  postdelivery. There were also examples of studies that conducted assessments at multiple time points demonstrating negative results. A study from China  reported that a mother’s nasopharyngeal swab specimens collected on her second day of hospital stay were positive for SARS-CoV-2 nucleic acid, while her breast milk samples collected on days two, nine, 16, and 19 after delivery were negative. In addition to the majority of evidence that demonstrated negative results, a small proportion of studies showed SARS-CoV-2 positive results in breast milk samples, including studies in Turkey [23, 33], Italy [19, 24, 34, 40], the USA , Mexico , Australia , India  and China .
The infectivity of breast milk from infected mothers
A study in the USA  reported that one breast milk sample from an infected mother tested positive for SARS-CoV-2 RNA. However, no replication-competent virus was detectable in this positive breast milk sample, which indicated that SARS-CoV-2 in breast milk may not be infectious. No additional studies that directly tested viral infectivity in breast milk were retrieved.
Four studies included in this review focused on the activity of the added SARS-CoV-2 in breast milk after pasteurization. Chambers et al.  added SARS-CoV-2 virus into breast milk and then used Holder pasteurization to pasteurize some of the samples. The authors failed to detect SARS-CoV-2 viral RNA or culturable virus in breast milk samples that underwent Holder pasteurization. In contrast, the nonpasteurization samples were found to be positive for viral RNA. A study in Canada  added SARS-CoV-2 to breast milk samples from a milk bank and then pasteurized these samples. The study showed that Holder pasteurization of human milk could inactivate SARS-CoV-2 . Similarly, an experiment in Australia  demonstrated that Holder pasteurization could inactivate replicative SARS-CoV-2, which was added to breast milk samples from healthy donors. Moreover, Conzelmann et al.  added SARS-CoV-2 into five breast milk samples. After pasteurization, no RNA particles were detected in these samples.
Other transmission modalities associated with breastfeeding
According to the mechanisms of SARS-CoV-2 transmission, the ways of mother-to-child transmission associated with breastfeeding may include close contact transmission and droplet transmission . Tam et al.  believed that the risk of environmental and patient’s own oropharynx contamination of breast milk was possible. Recent studies found that the external surfaces of breast milk containers could be contaminated by SARS-CoV-2. Kampf et al.  and van Doremalen et al.  reported that SARS-CoV-2 was more stable on plastic surfaces (i.e., contamination lasting 2–9 days) and glass surfaces (i.e., contamination lasting 4–5 days). These bottles could be potential sources of contamination and transmission.
The possible protective effect of breast milk from infected mothers
Nine studies included in this review showed that breast milk from infected mothers contained SARS-CoV-2-specific antibodies, which may be protective for children (Table 3). A study in Brazil detected IgA in a SARS-CoV-2-infected mother’s breast milk . In the USA, all breast milk samples from 18 infected women were reported to contain anti-SARS-CoV-2 IgA and IgG . Another study in the USA  detected breast milk samples from eight COVID-19-recovered and seven COVID-19-suspected women 3–4 weeks after symptoms had abated and found that 80% of samples contained IgA and 67% of samples contained IgG and/or IgM binding to the receptor-binding domain . A study in the Netherlands reported that 83% of the confirmed cases and 67% of the suspected cases had SARS-CoV-2 antibodies in their breast milk samples . A study in China  also detected anti-SARS-CoV-2 IgG and IgM in breast milk samples of 14 infected mothers . Another study in China detected IgM in 21 out of 38 breast milk samples of infected mothers . In addition, in the study of Fenizia et al. , anti-SARS-CoV-2 IgM was detected in breast milk from one confirmed mother. According to a case report  in China, anti-SARS-CoV-2 IgG was found in breast milk samples. Finally, COVID-19-positive mothers had breast milk antibodies against the S2 subunit SARS-CoV-2 . The majority of studies did not specify the value of antibody titers. Instead, some studies used graphs to show that antibody titers of milk samples from infected mothers were higher than those from control cases, while others studies stated this phenomenon in brief.
Current recommendations about breastfeeding
National and international organizations have provided different recommendations about breastfeeding during the COVID-19 pandemic [8, 10, 12,13,14,15,16, 70,71,72,73,74,75], which are described in detail in Table 4. In February 2020, the National Health Commission of the People’s Republic of China recommended stopping breastfeeding for mothers who were suspected/confirmed to have COVID-19 or had not recovered after diagnosis . If the nucleic acid test of the suspected infected mother was negative twice in a row, the newborn could be transferred out of the isolation and observation area and breastfed [14, 73]. In March 2020, ABM  suggested breastfeeding among infected mothers with recommendations in home and hospital settings. At home, confirmed mothers should remain separate from other family members, including the infant, except for the occasions of breastfeeding. In the hospital, if the mother was suspected or confirmed to have COVID-19, it was still reasonable to breastfeed or to provide expressed milk for her infant. In April 2020, ISS  recommended breastfeeding in a conservative manner. They suggested that asymptomatic or mildly affected mothers consider breastfeeding and rooming-in in coordination with healthcare providers. Separation with attempts to express breast milk to maintain milk production was recommended for severely or critically ill patients.
With much new evidence emerging in 2021, ISUOG [12, 76], WHO [8, 77, 78], AAP , CDC [70,71,72], UNICEF [16, 74], and RCOG  continued updating their breastfeeding recommendations. According to the current evidence, breast milk was unlikely to be the source of transmission of SARS-COV-2 [11, 67, 80, 81]; these organizations consistently recommended that mothers continue to breastfeed their infants with precautions if suspected or known to have COVID-19. The AAP  strongly supported breastfeeding as the best choice for infant feeding. The RCOG , UNICEF [16, 74], and WHO [8, 77, 78] suggested that suspected or infected mothers stay together with their infants after delivery, keep skin-to-skin contacts and breastfeed directly with careful precautions if mothers feel well. When a woman was not well enough to care for her infant or when direct breastfeeding was not possible, expressing breast milk could be considered. Pasteurized donor human milk was also recommended when mothers’ breast milk was not available by the WHO [8, 77, 78], CDC [70,71,72], UNICEF [16, 74], and RCOG . In contrast, the ISUOG  recommended breastfeeding in a conservative manner: whether to start breastfeeding should be decided by shared decision with the parents with consideration of healthcare providers’ advice.
Precautions for direct breastfeeding put forwards by the above organizations included washing hands before touching the infant, wearing a medical mask during any contacts with the infant, and routinely cleaning and disinfecting surfaces that mothers had touched. Precautions for expressing breast milk included wearing a mask during expression, washing hands before touching any pumps/bottle parts and expressing breast milk, following recommendations for proper pump cleaning after each use, and feeding expressed milk to the infant by a healthy caregiver who was not at risk for COVID-19, if possible.
The present review article summarizes the latest evidence about the safety of breastfeeding and the current recommendations on breastfeeding during the COVID-19 pandemic. The evidence summarization was generally based on van de Perre’s framework, which has been specifically used to assess the likelihood of viral infections during breastfeeding . Consistent with van de Perre et al. , we did not find any animal models related to SARS-CoV-2 transmission by breastfeeding. However, we found some evidence related to antibodies in breast milk samples and categorized them into the perspective of “the possible protective effect of breast milk from infected mothers”.
From the perspective of infants’ health status, current evidence suggests that infants breastfed by infected mothers might test positive for SARS-CoV-2; however, the population of infected infants was small. Our findings were consistent with a systematic review  that summarized evidence from 17 countries. The systematic review demonstrated that among 148 infants who were breastfed by infected mothers, only seven (4.9%) were infected; in comparison, 5.3% of formula-fed infants were infected. Similarly, a meta-analysis of 176 published cases reported that breastfeeding might not be associated with SARS-CoV-2 infections, and SARS-CoV-2 viral transmission through breast milk might be rare . However, there were studies  demonstrating positive results for SARS-CoV-2 among breastfed infants; therefore, vertical and respiratory transmission could not be ruled out. Moreover, the majority of the studies assessed infants at a single time point. Further studies to follow up the health status of breastfed infants are warranted to detect false positive results.
Of studies testing SARS-CoV-2 in breast milk, 66.7% (22/33) reported that milk samples from infected mothers were all negative, and 33.3% reported positive results. The reasons for positive results in some breast milk samples remain unclear. Bastug et al.  suggested that the viral load in breast milk, the testing method, the timing of sample collection, and the transport and storage of samples were potential contributors to the positive results. Therefore, the role of breast milk as a vehicle to transmit COVID-19 from mother to newborn could not be confirmed . Further studies are needed to collect breast milk samples from more cases in different regions and at multiple time points.
Few studies have directly tested the viral activity and infectivity of breast milk from infected mothers. Therefore, we could not confirm that SARS-CoV-2 in breast milk was infectious. Studies have focused on the activity of the added SARS-CoV-2 in breast milk after pasteurization. Pasteurization is an important method to eliminate viral and bacterial agents and ensure the safety of donated breast milk in human milk banks . Evidence included in our review suggested that pasteurized breast milk was an alternative and effective option for SARS-CoV-2-infected mothers who were not able to breastfeed directly . However, considering that some of the bioactive components in breast milk could be lost after pasteurization , pasteurized breast milk may not be the best choice.
Blackshaw et al.  listed infant feeding pathways and possible transmission modalities in their review. Our results were consistent with Blackshaw et al. , who found that transmission routes other than breast milk could not be ruled out during feeding. The potential routes included mother and other family members’ skin, bottle surfaces, etc.
This review included evidence showing that breast milk from infected mothers contained SARS-CoV-2-specific antibodies, which may be protective for children. This evidence supported Davanzo et al.’s hypothesis that specific antibodies of SARS-CoV-2 could be passed from the COVID-19-infected mother via breast milk to her infant within a few days after the onset of the disease and modulate the clinical expression of the infant’s infection . In addition, a previous review on vaccination and breastfeeding showed that anti-SARS-CoV-2 immunoglobulins may be transferred from healthy vaccinated lactating mothers to newborns through breastfeeding . In addition to SARS-CoV-2-specific antibodies, as confirmed in the literature, breast milk contains immunoglobulins that can protect infants from a variety of respiratory and digestive infections . For example, whey protein in human milk could block SARS-CoV-2 and its related pangolin coronavirus (GX_P2V) attachment and replication at entry and even post entry to inhibit the virus . Lactoferrin in breast milk can prevent viral infections and may protect infants and boost their innate immune system against COVID-19 [89, 90]. As a result, not breastfeeding could expose infants to a high risk of infections during the COVID-19 pandemic .
According to our results and the analytical framework, only two criteria (“viral infection in children breastfed by infected mothers”, and “the presence of virus/antigen/genome in the breast milk of infected mothers”) were met with limited evidence demonstrating positive results. Therefore, we believe that the breast milk of infected mothers is unlikely to transmit SARS-CoV-2. Moreover, a large amount of evidence was from case reports; studies with more robust designs are still lacking. Publication bias might also exist. We thus consider that the safety of breastfeeding during COVID-19 was insufficiently documented. Further studies to follow up the health status of infants who were directly breastfed by their confirmed/suspected infected mothers, to collect breast milk samples at multiple time points for viral tests and to examine specific antibodies in breast milk samples are warranted.
We found that recommendations on breastfeeding during COVID-19 from different organizations were controversial. Similarly, a previous review found that the aspects in the guidance documents from 33 countries were poorly consistent with the WHO guidelines . The other study found that in 73 articles, recommendations regarding breastfeeding, separation of mother and newborns after birth and decontamination practices were varied . In our review, China seemed to have stricter measures about breastfeeding. Chinese experts thought that breastfeeding should be stopped among confirmed or suspected mothers, as the possibility of the vertical transmission of COVID-19 could not be completely ruled out [93, 94]. The ISS and ISUOG also recommended breastfeeding in a conservative manner. They thought decisions towards breastfeeding should be made by mothers and their family members, with the consideration of healthcare providers’ advice [10, 76]. In comparison, other organizations (e.g., ABM, WHO, AAP, CDC, UNICEF, and RCOG) encouraged breastfeeding among suspected or confirmed infected mothers. Indeed, the currently available scientific evidence does not allow us to accurately inform the best practices of breastfeeding during the COVID-19 pandemic . As new evidence accumulates, recommendations should be updated in a timely manner to ensure appropriate practices.
This article provides comprehensive evidence for the safety and recommendations of breastfeeding during the COVID-19 pandemic. Based on an analytical framework, the current evidence proved that transmission of SARS-CoV-2 from infected mothers via breast milk was unlikely to happen. However, owing to the low quality of the current evidence, the safety of breastfeeding during COVID-19 is still insufficiently reported. Further studies with robust designs are warranted to determine the safety of breastfeeding. Studies to follow up the health status of infants who were breastfed by confirmed/suspected infected mothers, to conduct viral tests on breast milk samples at multiple time points and to examine specific antibodies in breast milk samples are needed to fill the research gaps. This review contributed to the literature by providing scientific evidence and recommendations on breastfeeding and identifying the focus for further research during the COVID-19 pandemic.
Availability of data and materials
American Academy of Pediatrics
Academy of Breastfeeding Medicine
U.S. Centers for Disease Control and Prevention
China National Knowledge Infrastructure
Coronavirus Disease 2019
Italian National Institute of Health
International Society of Ultrasound in Obstetrics and Gynecology
Royal College of Obstetricians and Gynecologists
Severe Acute Respiratory Syndrome Coronavirus 2
United Nations International Children’s Emergency Fund
World Health Organization
World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed 4 Jun 2021.
World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020. Accessed Jan 15 2021.
World Health Organization. WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int. Accessed 4 Nov 2021.
Pan American Health Organization, World Health Organization. Epidemiological update: Coronavirus disease (COVID-19). 23 December 2021, Washington, D.C.: PAHO/WHO; 2021.
Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139:103122.
Biasucci G, Cannalire G, Raymond A, Capra ME, Benenati B, Vadacca G, et al. Safe perinatal management of neonates born to SARS-CoV-2 positive mothers at the epicenter of the Italian epidemic. Front Pediatr. 2020;8:565522.
Aghaeepour N, Ganio EA, McIlwain D, Tsai AS, Tingle M, Van Gassen S, et al. An immune clock of human pregnancy. Sci Immunol. 2017;2(15):eaan2946.
World Health Organization. Q&A on COVID-19 and breastfeeding. https://www.who.int/news-room/q-a-detail/q-a-on-covid-19-and-breastfeeding. Accessed 4 Jun 2021.
Davanzo R. Breast feeding at the time of COVID-19: do not forget expressed mother's milk, please. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):455.
Davanzo R, Moro G, Sandri F, Agosti M, Moretti C, Mosca F. Breastfeeding and coronavirus disease-2019: ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & perinatal societies. Matern Child Nutr. 2020;16(3):e13010.
Walker KF, O'Donoghue K, Grace N, Dorling J, Comeau JL, Li W, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG. 2020;127(11):1324–36.
Poon LC, Yang H, Lee JCS, Copel JA, Leung TY, Zhang Y, et al. ISUOG interim guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020;55(5):700–8.
Academy of Breastfeeding Medicine. ABM statement on coronavirus 2019 (COVID-19). https://www.bfmed.org/abm-statement-coronavirus. Accessed 4 Jun 2021.
National Health Commission of the People’s Republic of China. [Notice on COVID-19 infection prevention and control work for children and pregnant women]. http://www.nhc.gov.cn/fys/s7902/202002/de2d62a5711c41ef9b2c4b6f4d1f2136.shtml. Accessed 4 Jun 2021.
Royal College of Obstetricians & Gynecologists. Coronavirus (COVID-19) infection in pregnancy. Information for healthcare professionals. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-pregnancy/. Accessed 4 Jun 2021.
United Nations International Children’s Emergency Fund. Navigating pregnancy during the coronavirus disease (COVID-19) pandemic. https://www.unicef.org/coronavirus/navigating-pregnancy-during-coronavirus-disease-covid-19-pandemic. Accessed 4 Jun 2021.
Van de Perre P, Molès JP, Nagot N, Tuaillon E, Ceccaldi PE, Goga A, et al. Revisiting Koch's postulate to determine the plausibility of viral transmission by human milk. Pediatr Allergy Immunol. 2021;32(5):835–42.
Ajith S, Reshmi VP, Nambiar S, Naser A, Athulya B. Prevalence and risk factors of neonatal Covid-19 infection: a single-Centre observational study. J Obstet Gynaecol India. 2021;71(3):1–4.
Bertino E, Moro GE, De Renzi G, Viberti G, Cavallo R, Coscia A, et al. Detection of SARS-CoV-2 in milk from COVID-19 positive mothers and follow-up of their infants. Front Pediatr. 2020;8:597699.
Chu H, Li J, Yan J, Bai T, Schnabl B, Zou L, et al. Persistent SARS-CoV-2 RNA positive in feces but negative in breastmilk: a case report of COVID-19 in a breastfeeding patient. Front Med. 2020;7:562700.
Cojocaru L, Crimmins S, Sundararajan S, Goetzinger K, Elsamadicy E, Lankford A, et al. An initiative to evaluate the safety of maternal bonding in patients with SARS-CoV-2 infection. J Matern Fetal Neonatal Med, Online ahead of print. 2020. https://doi.org/10.1080/14767058.2020.1828335.
Gao X, Wang S, Zeng W, Chen S, Wu J, Lin X, et al. Clinical and immunologic features among COVID-19-affected mother-infant pairs: antibodies to SARS-CoV-2 detected in breast milk. New Microbes New Infect. 2020;37:100752.
Kilic T, Kilic S, Berber NK, Gunduz A, Ersoy Y. Investigation of SARS-CoV-2 RNA in milk produced by women with COVID-19 and follow-up of their infants: a preliminary study. Int J Clin Pract. 2021;75(7):e14175.
Lugli L, Bedetti L, Lucaccioni L, Gennari W, Leone C, Ancora G, et al. An uninfected preterm newborn inadvertently fed SARS-CoV-2-positive breast milk. Pediatrics. 2020;146(6):e2020004960.
Oncel MY, Akin IM, Kanburoglu MK, Tayman C, Coskun S, Narter F, et al. A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish neonatal society. Eur J Pediatr. 2021;180(3):733–42.
Pereira A, Cruz-Melguizo S, Adrien M, Fuentes L, Marin E, Forti A, et al. Breastfeeding mothers with COVID-19 infection: a case series. Int Breastfeed J. 2020;15:69.
Piersigilli F, Carkeek K, Hocq C, van Grambezen B, Hubinont C, Chatzis O, et al. COVID-19 in a 26-week preterm neonate. Lancet Child Adolesc Health. 2020;4(6):476–8.
Salvatore CM, Han JY, Acker KP, Tiwari P, Jin J, Brandler M, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020;4(10):721–7.
Savasi VM, Parisi F, Patanè L, Ferrazzi E, Frigerio L, Pellegrino A, et al. Clinical findings and disease severity in hospitalized pregnant women with coronavirus cisease 2019 (COVID-19). Obstet Gynecol. 2020;136(2):252–8.
Shlomai NO, Kasirer Y, Strauss T, Smolkin T, Marom R, Shinwell ES, et al. Neonatal SARS-CoV-2 infections in breastfeeding mothers. Pediatrics. 2021;147(5):e2020010918.
Tran HT, Huynh LT, Le CHM, Nguyen VD, Nguyen PTT, Hoang DT, et al. Early essential newborn care can still be used with mothers who have COVID-19 if effective infection control measures are applied. Acta Paediatr. 2021;110(7):1991–4.
Vila-Candel R, Mena-Tudela D, Gomez-Segui A, Asensio-Tomas N, Cervera-Gasch A, Herraiz-Soler Y. Management of labour, puerperium, and lactation in SARS-CoV-2 positive women. Multicentric study in the Valencian community. Enferm Clin (Engl Ed). 2021;31(3):184–8.
Bastug A, Hanifehnezhad A, Tayman C, Ozkul A, Ozbay O, Kazancioglu S, et al. Virolactia in an asymptomatic mother with COVID-19. Breastfeed Med. 2020;15(8):488–91.
Buonsenso D, Costa S, Sanguinetti M, Cattani P, Posteraro B, Marchetti S, et al. Neonatal late onset infection with severe acute respiratory syndrome coronavirus 2. Am J Perinatol. 2020;37(8):869–72.
Chambers C, Krogstad P, Bertrand K, Contreras D, Tobin NH, Bode L, et al. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA. 2020;324(13):1347–8.
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–15.
Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L, et al. A 55-day-old female infant infected with 2019 novel coronavirus disease: presenting with pneumonia, liver injury, and heart damage. J Infect Dis. 2020;221(11):1775–81.
Dong L, Tian J, He S, Zhu C, Wang J, Liu C, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020;323(18):1846–8.
Fan C, Lei D, Fang C, Li C, Wang M, Liu Y, et al. Perinatal transmission of 2019 coronavirus disease-associated severe acute respiratory syndrome coronavirus 2: should we worry? Clin Infect Dis. 2021;72(5):862–4.
Fenizia C, Biasin M, Cetin I, Vergani P, Mileto D, Spinillo A, et al. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat Commun. 2020;11:5128.
Han MS, Seong MW, Heo EY, Park JH, Kim N, Shin S, et al. Sequential analysis of viral load in a neonate and her mother infected with severe acute respiratory syndrome coronavirus 2. Clin Infect Dis. 2020;71(16):2236–9.
Hinojosa-Velasco A, Bobadilla-Montes de Oca PV, Garcia-Sosa LE, Gabriel Mendoza-Duran J, Perez-Mendez MJ, Davila-Gonzalez E, et al. A case report of newborn infant with severe COVID-19 in Mexico: detection of SARS-CoV-2 in human breast milk and stool. Int J Infect Dis. 2020;100:21–4.
Kalafat E, Yaprak E, Cinar G, Varli B, Ozisik S, Uzun C, et al. Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19. Ultrasound Obstet Gynecol. 2020;55(6):835–7.
Kam KQ, Yung CF, Cui L, Tzer Pin Lin R, Mak TM, Maiwald M, et al. A well infant with coronavirus disease 2019 with high viral load. Clin Infect Dis. 2020;71(15):847–9.
Lei D, Wang C, Li C, Fang C, Yang W, Chen B, et al. Clinical characteristics of COVID-19 in pregnancy:analysis of nine cases. Chin J Perinat Med. 2020;23(3):159–65.
Liu W, Wang J, Li W, Zhou Z, Liu S, Rong Z. Clinical characteristics of 19 neonates born to mothers with COVID-19. Front Med. 2020;14(2):193–8.
Marin Gabriel MA, Malalana Martinez AM, Marin Martinez ME, Anel PJ. Negative transmission of SARS-CoV-2 to hand-expressed colostrum from SARS-CoV-2-positive mothers. Breastfeed Med. 2020;15(8):492–4.
Mattar CNZ, Kalimuddin S, Sadarangani SP, Tagore S, Thain S, Thoon KC, et al. Pregnancy outcomes in COVID-19: a prospective cohort study in Singapore. Ann Acad Med Singap. 2020;49(11):857–69.
Pace RM, Williams JE, Jarvinen KM, Belfort MB, Pace CDW, Lackey KA, et al. Characterization of SARS-CoV-2 RNA, antibodies, and neutralizing capacity in milk produced by women with COVID-19. mBio. 2021;12(1):e03192–20.
Peng S, Zhu H, Yang L, Cao L, Huang X, Dynes M, et al. A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19. Lancet Reg Health West Pac. 2020;4:100045.
Peng Z, Wang J, Mo Y, Duan W, Xiang G, Yi M, et al. Unlikely SARS-CoV-2 vertical transmission from mother to child: a case report. J Infect Public Health. 2020;13(5):818–20.
Sharma R, Seth S, Sharma R, Yadav S, Mishra P, Mukhopadhyay S. Perinatal outcome and possible vertical transmission of coronavirus disease 2019: experience from North India. Clin Exp Pediatr. 2021;64(5):239–46.
Tam PCK, Ly KM, Kernich ML, Spurrier N, Lawrence D, Gordon DL, et al. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;72(1):128–30.
Thanigainathan S, Kaliyaperumal V, Sivanandan S, Rengaraj S, Dhodapkar R, Bethou A. Is SARS-CoV-2 transmitted through breastfeeding? Indian J Pediatr. 2021;88(8):800–1.
Wang S, Guo L, Chen L, Liu W, Cao Y, Zhang J, et al. A case report of neonatal 2019 coronavirus disease in China. Clin Infect Dis. 2020;71(15):853–7.
Wu Y, Liu C, Dong L, Zhang C, Chen Y, Liu J, et al. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding. BJOG. 2020;127(9):1109–15.
Xiong X, Wei H, Zhang Z, Chang J, Ma X, Gao X, et al. Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID--19. J Med Virol. 2020;92(9):1657–9.
Yu Y, Li Y, Hu Y, Li B, Xu J. Breastfed 13 month-old infant of a mother with COVID-19 pneumonia: a case report. Int Breastfeed J. 2020;15:68.
Zhuang S, Guan J, Cao Y, Chen H, Xu D, Li J, et al. Perinatal COVID-19: a case report. Chin J Perinat Med. 2020;23(2):85–90.
Unger S, Christie-Holmes N, Guvenc F, Budylowski P, Mubareka S, Gray-Owen SD, et al. Holder pasteurization of donated human milk is effective in inactivating SARS-CoV-2. CMAJ. 2020;192(31):E871–E4.
Walker GJ, Clifford V, Bansal N, Stella AO, Turville S, Stelzer-Braid S, et al. SARS-CoV-2 in human milk is inactivated by holder pasteurisation but not cold storage. J Paediatr Child Health. 2020;56(12):1872–4.
Conzelmann C, Gross R, Meister TL, Todt D, Krawczyk A, Dittmer U, et al. Pasteurization inactivates SARS-CoV-2-spiked breast milk. Pediatrics. 2021;147(1):e2020031690.
Wang SS, Zhou X, Lin XG, Liu YY, Wu JL, Sharifu LM, et al. Experience of clinical management for pregnant women and newborns with novel coronavirus pneumonia in Tongji Hospital, China. Curr Med Sci. 2020;40(2):285–9.
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–51.
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–7.
Demers-Mathieu V, DaPra C, Mathijssen G, Sela DA, Jarvinen KM, Seppo A, et al. Human milk antibodies against S1 and S2 subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in mothers with a confirmed COVID-19 PCR, viral symptoms, and unexposed mothers. Int J Mol Sci. 2021;22(4):1749.
Fox A, Marino J, Amanat F, Krammer F, Hahn-Holbrook J, Zolla-Pazner S, et al. Robust and specific secretory IgA against SARS-CoV-2 detected in human milk. iScience. 2020;23(11):101735.
Lebrao CW, Cruz MN, da Silva MH, Dutra LV, Cristiani C, Affonso Fonseca FL, et al. Early identification of IgA anti-SARSCoV-2 in milk of mother with COVID-19 infection. J Hum Lact. 2020;36(4):609–13.
van Keulen BJ, Romijn M, Bondt A, Dingess KA, Kontopodi E, van der Straten K, et al. Human milk from previously covid-19-infected mothers: the effect of pasteurization on specific antibodies and neutralization capacity. Nutrients. 2021;13(5):1645.
Centers for Disease Control and Prevention. Coronavirus disease (COVID-19) and breastfeeding. https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/covid-19-and-breastfeeding.html. Accessed 4 Jun 2021.
Centers for Disease Control and Prevention. Evaluation and management considerations for neonates at risk for COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html. Accessed 4 Jun 2021.
Centers for Disease Control and Prevention. Interim guidance on breastfeeding and breast milk feeds in the context of COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/care-for-breastfeeding-women.html. Accessed 4 Jun 2021.
Zhu LQM, Li L, Xu B, Lu J, Zhu L. Health care management of pregnancy and childbirth system during COVID-19 in Shanghai. Chin J Fam Plan Gynecotokol. 2020;12(3):94–6.
United Nations International Children’s Emergency Fund. Breastfeeding safely during the COVID-19 pandemic. https://www.unicef.org/coronavirus/breastfeeding-safely-during-covid-19-pandemic. Accessed 4 Jun 2021.
American Academy of Pediatrics. Breastfeeding guidancepost hospital discharge for mothers or infants with suspected or confirmed SARS-Co V-2 infection. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/. Accessed 4 Jun 2021.
International Society of Ultrasound in Obstetrics and Gynecology. New ISUOG interim guidance - 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals - an update. https://www.isuog.org/clinical-resources/coronavirus-covid-19-resources/research-and-journal/interim-guidance-coronavirus-pregnancy-puerperium.html. Accessed 4 Jun 2021.
World Health Organization. Breastfeeding and COVID-19: scientific brief. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Breastfeeding-2020.1. Accessed 4 Jun 2021.
World Health Organization. COVID-19 clinical management: living guidance (25 January 2021). Geneva; 2021.
World Health Organization. Clinical management of COVID-19: interim guidance (27 May 2020). Geneva: World Health Organization; 2020.
Martins-Filho PR, Santos VS, Santos HP Jr. To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19. Rev Panam Salud Publica. 2020;44:e59.
Golan Y, Prahl M, Cassidy AG, Gay C, Wu AHB, Jigmeddagva U, et al. COVID-19 mRNA vaccination in lactation: assessment of adverse events and vaccine related antibodies in mother-infant dyads. Front Immunol. 2021;12:777103.
Raschetti R, Vivanti AJ, Vauloup-Fellous C, Loi B, Benachi A, De Luca D. Synthesis and systematic review of reported neonatal SARS-CoV-2 infections. Nat Commun. 2020;11:5164.
Cheema R, Partridge E, Kair LR, Kuhn-Riordon KM, Silva AI, Bettinelli ME, et al. Protecting breastfeeding during the COVID-19 pandemic. Am J Perinatol. 2020. Online ahead of print. https://doi.org/10.1055/s-0040-1714277.
Peila C, Moro GE, Bertino E, Cavallarin L, Giribaldi M, Giuliani F, et al. The effect of holder pasteurization on nutrients and biologically-active components in donor human milk: a review. Nutrients. 2016;8(8):477.
Blackshaw K, Valtchev P, Koolaji N, Berry N, Schindeler A, Dehghani F, et al. The risk of infectious pathogens in breast-feeding, donated human milk and breast milk substitutes. Public Health Nutr. 2021;24(7):1725–40.
Falsaperla R, Leone G, Familiari M, Ruggieri M. COVID-19 vaccination in pregnant and lactating women: a systematic review. Expert Rev Vaccines. 2021;20(12):1619–28.
Van de Perre P. Transfer of antibody via mother's milk. Vaccine. 2003;21(24):3374–6.
Fan H, Hong B, Luo Y, Peng Q, Wang L, Jin X, et al. The effect of whey protein on viral infection and replication of SARS-CoV-2 and pangolin coronavirus in vitro. Signal Transduct Target Ther. 2020;5:275.
AlKhazindar M, Elnagdy SM. Can lactoferrin boost human immunity against COVID-19? Pathog Glob Health. 2020;114(5):234–5.
Peroni DG, Fanos V. Lactoferrin is an important factor when breastfeeding and COVID-19 are considered. Acta Paediatr. 2020;109(10):2139–40.
Vu Hoang D, Cashin J, Gribble K, Marinelli K, Mathisen R. Misalignment of global COVID-19 breastfeeding and newborn care guidelines with World Health Organization recommendations. BMJ Nutr Prev Health. 2020;3(2):339–50.
DiLorenzo MA, O'Connor SK, Ezekwesili C, Sampath S, Zhao M, Yarrington C, et al. COVID-19 guidelines for pregnant women and new mothers: a systematic evidence review. Int J Gynaecol Obstet. 2021;153(3):373–82.
Wang L, Shi Y, Xiao T, Fu J, Feng X, Mu D, et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (first edition). Ann Transl Med. 2020;8(3):47.
Lang G, Zhao H. Can SARS-CoV-2-infected women breastfeed after viral clearance? J Zhejiang Univ Sci B. 2020;21(5):405–7.
This work was supported by Peking University Research Initiation Fund [grant number BMU2018YJ005]. The funding body had no role in the design of the study, the collection, analysis, and interpretation of the data or the writing of this article.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liu, X., Chen, H., An, M. et al. Recommendations for breastfeeding during Coronavirus Disease 2019 (COVID-19) pandemic. Int Breastfeed J 17, 28 (2022). https://doi.org/10.1186/s13006-022-00465-w